TREATMENT OF CANCER USING GFR ALPHA-4 CHIMERIC ANTIGEN RECEPTOR
摘要
The present disclosure relates to compositions and methods for treating diseases, disorders or conditions associated with the expression of the Glycosyl-phosphatidylinositol (GPI)-linked GDNF family a-receptor 4 (GFRa4).
申请公布号
WO2016025880(A1)
申请公布日期
2016.02.18
申请号
WO2015US45349
申请日期
2015.08.14
申请人
NOVARTIS AG;THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA;SIEGEL, DONALD, L.;MILONE, MICHAEL, C.;BHOJ, VIJAY
